Fluvoxamine 100 mg/day + placebo for 10 weeks as control group

3 trials

Sponsors

Tehran University of Medical Sciences

Conditions

Obsessive- Cumpulsive Disorder. Obsessive-compulsive disorderObsessive-compulsive disorder. Obsessive-compulsive disorder

Phase 3

Minocycline in the treatment OCD

Active, not recruitingIRCT201501031556N70

Tehran University of Medical SciencesObsessive-compulsive disorder. Obsessive-compulsive disorder

Start: 2015-01-21Target: 50Updated: 2018-02-22

Unknown Phase

N-Acetyle-Cysteine in the treatment of obsessive-compulsive disorder

Active, not recruitingIRCT201405271556N60

Tehran University of Medical SciencesObsessive- Cumpulsive Disorder. Obsessive-compulsive disorder

Start: 2014-06-22Target: 50Updated: 2018-02-22

L-Carnosine in the treatment of OCD

Active, not recruitingIRCT201604201556N88

Tehran University of Medical SciencesObsessive- Cumpulsive Disorder. Obsessive-compulsive disorder

Start: 2016-05-04Target: 50Updated: 2018-02-22

Related Papers

N-acetylcysteine augmentation therapy for moderate-to-severe obsessive-compulsive disorder: randomized, double-blind, placebo-controlled trial

Journal of Clinical Pharmacy and Therapeutics2016-03-02102 citations